Piramal acquires Cipla's OTC emergency contraceptive brand
This article was originally published in Scrip
Executive Summary
Piramal Healthcare has acquired Cipla's popular over-the-counter emergency contraceptive brand, i-pill, for Rs950 million ($20.8 million).